Eli Lilly and Company has announced plans to invest $6.5 billion in a new manufacturing facility at Generation Park in northeast Houston, which is expected to create 615 permanent jobs and 4,000 temporary construction jobs. The facility will focus on manufacturing small molecule medicines, including a new oral medication for Type 2 diabetes and obesity. Lilly anticipates that for each dollar spent, an additional four dollars will be generated in the local economy. This initiative aligns with efforts to establish Generation Park as a life sciences hub, supported by local educational institutions to provide a skilled workforce. The facility is projected to break ground this year and become operational within five years.
Disclaimer: This summary is written by AI, which can make mistakes. Please follow up on any news information from additional sources.
Link to original article source: https://communityimpact.com/lake-houston-humble-kingwood/development/biotech-boom-65b-manufacturing-facility-at-generation-park-to-expand-life-sciences-in-houston/
